These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

270 related articles for article (PubMed ID: 18842735)

  • 1. Mechanism of antiviral drug resistance of vaccinia virus: identification of residues in the viral DNA polymerase conferring differential resistance to antipoxvirus drugs.
    Gammon DB; Snoeck R; Fiten P; Krecmerová M; Holý A; De Clercq E; Opdenakker G; Evans DH; Andrei G
    J Virol; 2008 Dec; 82(24):12520-34. PubMed ID: 18842735
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cidofovir resistance in vaccinia virus is linked to diminished virulence in mice.
    Andrei G; Gammon DB; Fiten P; De Clercq E; Opdenakker G; Snoeck R; Evans DH
    J Virol; 2006 Oct; 80(19):9391-401. PubMed ID: 16973545
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mutations conferring resistance to viral DNA polymerase inhibitors in camelpox virus give different drug-susceptibility profiles in vaccinia virus.
    Duraffour S; Andrei G; Topalis D; Krečmerová M; Crance JM; Garin D; Snoeck R
    J Virol; 2012 Jul; 86(13):7310-25. PubMed ID: 22532673
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mutations in the E9L polymerase gene of cidofovir-resistant vaccinia virus strain WR are associated with the drug resistance phenotype.
    Kornbluth RS; Smee DF; Sidwell RW; Snarsky V; Evans DH; Hostetler KY
    Antimicrob Agents Chemother; 2006 Dec; 50(12):4038-43. PubMed ID: 16982794
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antiviral potential of a new generation of acyclic nucleoside phosphonates, the 6-[2-(phosphonomethoxy)alkoxy]-2,4-diaminopyrimidines.
    De Clercq E; Andrei G; Balzarini J; Leyssen P; Naesens L; Neyts J; Pannecouque C; Snoeck R; Ying C; Hocková D; Holý A
    Nucleosides Nucleotides Nucleic Acids; 2005; 24(5-7):331-41. PubMed ID: 16247948
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The 3'-to-5' exonuclease activity of vaccinia virus DNA polymerase is essential and plays a role in promoting virus genetic recombination.
    Gammon DB; Evans DH
    J Virol; 2009 May; 83(9):4236-50. PubMed ID: 19224992
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The antiviral activity and mechanism of action of (S)-[3-hydroxy-2-(phosphonomethoxy)propyl] (HPMP) nucleosides.
    Magee WC; Evans DH
    Antiviral Res; 2012 Nov; 96(2):169-80. PubMed ID: 22960154
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Isolation and characterization of cidofovir resistant vaccinia viruses.
    Becker MN; Obraztsova M; Kern ER; Quenelle DC; Keith KA; Prichard MN; Luo M; Moyer RW
    Virol J; 2008 May; 5():58. PubMed ID: 18479513
    [TBL] [Abstract][Full Text] [Related]  

  • 9. DNA polymerase mutations in drug-resistant herpes simplex virus mutants determine in vivo neurovirulence and drug-enzyme interactions.
    Andrei G; Fiten P; Froeyen M; De Clercq E; Opdenakker G; Snoeck R
    Antivir Ther; 2007; 12(5):719-32. PubMed ID: 17713155
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Therapeutic potential of nucleoside/nucleotide analogues against poxvirus infections.
    De Clercq E; Neyts J
    Rev Med Virol; 2004; 14(5):289-300. PubMed ID: 15334537
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Characterization of wild-type and cidofovir-resistant strains of camelpox, cowpox, monkeypox, and vaccinia viruses.
    Smee DF; Sidwell RW; Kefauver D; Bray M; Huggins JW
    Antimicrob Agents Chemother; 2002 May; 46(5):1329-35. PubMed ID: 11959564
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cidofovir and (S)-9-[3-hydroxy-(2-phosphonomethoxy)propyl]adenine are highly effective inhibitors of vaccinia virus DNA polymerase when incorporated into the template strand.
    Magee WC; Aldern KA; Hostetler KY; Evans DH
    Antimicrob Agents Chemother; 2008 Feb; 52(2):586-97. PubMed ID: 18056278
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Activities of several classes of acyclic nucleoside phosphonates against camelpox virus replication in different cell culture models.
    Duraffour S; Snoeck R; Krecmerová M; van Den Oord J; De Vos R; Holy A; Crance JM; Garin D; De Clercq E; Andrei G
    Antimicrob Agents Chemother; 2007 Dec; 51(12):4410-9. PubMed ID: 17893157
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A point mutation in the human cytomegalovirus DNA polymerase gene selected in vitro by cidofovir confers a slow replication phenotype in cell culture.
    Cihlar T; Fuller MD; Mulato AS; Cherrington JM
    Virology; 1998 Sep; 248(2):382-93. PubMed ID: 9721246
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Topical treatment of cutaneous vaccinia virus infections in immunosuppressed hairless mice with selected antiviral substances.
    Smee DF; Bailey KW; Wong MH; Tarbet EB
    Antivir Chem Chemother; 2011 May; 21(5):201-8. PubMed ID: 21566266
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Synthesis of ester prodrugs of 9-(S)-[3-hydroxy-2-(phosphonomethoxy)propyl]-2,6-diaminopurine (HPMPDAP) as anti-poxvirus agents.
    Krecmerová M; Holý A; Andrei G; Pomeisl K; Tichý T; Brehová P; Masojídková M; Dracínský M; Pohl R; Laflamme G; Naesens L; Hui H; Cihlar T; Neyts J; De Clercq E; Balzarini J; Snoeck R
    J Med Chem; 2010 Oct; 53(19):6825-37. PubMed ID: 20809641
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Vaccinia virus inhibitors as a paradigm for the chemotherapy of poxvirus infections.
    De Clercq E
    Clin Microbiol Rev; 2001 Apr; 14(2):382-97. PubMed ID: 11292644
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Characterization and treatment of cidofovir-resistant vaccinia (WR strain) virus infections in cell culture and in mice.
    Smee DF; Wandersee MK; Bailey KW; Hostetler KY; Holy A; Sidwell RW
    Antivir Chem Chemother; 2005; 16(3):203-11. PubMed ID: 16004083
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antiviral activities of 2,6-diaminopurine-based acyclic nucleoside phosphonates against herpesviruses: In vitro study results with pseudorabies virus (PrV, SuHV-1).
    Zouharova D; Lipenska I; Fojtikova M; Kulich P; Neca J; Slany M; Kovarcik K; Turanek-Knotigova P; Hubatka F; Celechovska H; Masek J; Koudelka S; Prochazka L; Eyer L; Plockova J; Bartheldyova E; Miller AD; Ruzek D; Raska M; Janeba Z; Turanek J
    Vet Microbiol; 2016 Feb; 184():84-93. PubMed ID: 26854349
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Acyclic nucleoside phosphonates: past, present and future. Bridging chemistry to HIV, HBV, HCV, HPV, adeno-, herpes-, and poxvirus infections: the phosphonate bridge.
    De Clercq E
    Biochem Pharmacol; 2007 Apr; 73(7):911-22. PubMed ID: 17045247
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.